Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

AstraZeneca describes TAK1 inhibitor with potential for treating mantle cell lymphoma

Dec. 14, 2009

Recent studies of dengue vaccines presented at the ASTMH meeting

Dec. 14, 2009

KNS-760704 is well tolerated and may be beneficial in treating amyotrophic lateral sclerosis

Dec. 14, 2009

An exploratory memantine trial in amyotrophic lateral sclerosis produces discouraging results

Dec. 14, 2009

Tolerability and pharmacokinetic evaluations of ceftriaxone completed in ALS patients

Dec. 11, 2009

Phase I results show oncolytic virotherapy with DWP-418 feasible, well tolerated

Dec. 11, 2009

Phase I studies of products utilizing ImmunoGen's TAP technology presented at ASH meeting

Dec. 11, 2009

Responses seen in CLL patients given cenersen added to chemo-immunotherapy

Dec. 11, 2009

JAK2 inhibitor SB-1518 shows promise against hematological malignancies

Dec. 11, 2009

Rufinamide efficacious in adults and children with epilepsy

Dec. 10, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...